{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:49:22Z","timestamp":1794368962817,"version":"4.9.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930103"],"award-info":[{"award-number":["81930103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111322","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T08:13:18Z","timestamp":1613549598000},"page":"111322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3672-8365","authenticated-orcid":false,"given":"Abdoh","family":"Taleb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-5039","authenticated-orcid":false,"given":"Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-2824","authenticated-orcid":false,"given":"Kohji","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111322_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.05.007","article-title":"Autism spectrum disorder: classification, diagnosis and therapy","volume":"190","author":"Sharma","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"10146","key":"10.1016\/j.biopha.2021.111322_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.111322_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yebeh.2018.06.023","article-title":"Children with autism spectrum disorders and drug-resistant epilepsy can benefit from epilepsy surgery","volume":"85","author":"Morrison-Levy","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2021.111322_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2018.00257","article-title":"The diagnosis of autism Spectrum disorder based on the random neural network cluster","volume":"12","author":"Bi","year":"2018","journal-title":"Front. Hum. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2021.111322_bib0025","first-page":"972","article-title":"Autism Spectrum disorder: primary care principles","volume":"94","author":"Sanchack","year":"2016","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"10.1016\/j.biopha.2021.111322_bib0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s10803-006-0237-4","article-title":"Social communication profiles of children with autism spectrum disorders late in the second year of life","volume":"37","author":"Wetherby","year":"2007","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-017-0100-y","article-title":"An overview of autism Spectrum disorder, heterogeneity and treatment options","volume":"33","author":"Masi","year":"2017","journal-title":"Neurosci. Bull."},{"issue":"87","key":"10.1016\/j.biopha.2021.111322_bib0040","first-page":"1","article-title":"Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 national health interview survey","author":"Zablotsky","year":"2015","journal-title":"Health Stat. Report."},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6904a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2016","volume":"69","author":"Maenner","year":"2020","journal-title":"Mmwr Surveill. Summ."},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1362361309104246","article-title":"Economic cost of autism in the UK","volume":"13","author":"Knapp","year":"2009","journal-title":"Autism"},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YCO.0000000000000308","article-title":"Autism spectrum disorder: outcomes in adulthood","volume":"30","author":"Howlin","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111322_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neubiorev.2017.06.005","article-title":"Conceptualising compensation in neurodevelopmental disorders: reflections from autism spectrum disorder","volume":"80","author":"Livingston","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pop.2016.01.010","article-title":"Autism spectrum\/pervasive developmental disorder","volume":"43","author":"Yochum","year":"2016","journal-title":"Prim. Care"},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.mehy.2011.02.038","article-title":"A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder","volume":"76","author":"Buehler","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2021.111322_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","article-title":"Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting","volume":"1380","author":"Betancur","year":"2011","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.biopha.2021.111322_bib0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twin pairs with autism","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jped.2016.09.002","article-title":"Autism in 2016: the need for answers","volume":"93","author":"Posar","year":"2017","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pd.4942","article-title":"Autism genetics - an overview","volume":"37","author":"Yin","year":"2017","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/aur.116","article-title":"Independent and dependent contributions of advanced maternal and paternal ages to autism risk","volume":"3","author":"Shelton","year":"2010","journal-title":"Autism Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mehy.2009.07.052","article-title":"Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder","volume":"74","author":"Kinney","year":"2010","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ije\/dyt282","article-title":"Maternal lifestyle and environmental risk factors for autism spectrum disorders","volume":"43","author":"Lyall","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.biopha.2021.111322_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111322_bib0115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2021.111322_bib0120","first-page":"1","article-title":"Valproic acid in pregnancy: valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy- a pilot longitudinal study","author":"Qiu","year":"2020","journal-title":"J. Biomed. Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.111322_bib0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-017-0809-3","article-title":"Valproic acid in women and girls of childbearing age","volume":"19","author":"Gotlib","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111322_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxlet.2007.08.006","article-title":"Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy","volume":"174","author":"Ogawa","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2021.111322_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","article-title":"Prenatal factors associated with autism spectrum disorder (ASD)","volume":"56","author":"Ornoy","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111322_bib0140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/epi.13007","article-title":"Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy","volume":"56","author":"Wood","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2021.111322_bib0145","first-page":"712758","article-title":"What we have learned about autism spectrum disorder from valproic acid","volume":"2013","author":"Chomiak","year":"2013","journal-title":"Patholog. Res. Int."},{"key":"10.1016\/j.biopha.2021.111322_bib0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","article-title":"Prenatal factors associated with autism spectrum disorder (ASD)","volume":"56","author":"Ornoy","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2021.111322_bib0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000492113","article-title":"Neuroimmune alterations in autism: a translational analysis focusing on the animal model of autism induced by prenatal exposure to valproic acid","volume":"25","author":"Deckmann","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biopha.2021.111322_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2021.111322_bib0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12906-017-1763-7","article-title":"Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism","volume":"17","author":"Al-Askar","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111322_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2014.00053","article-title":"Gene x environment interactions in autism spectrum disorders: role of epigenetic mechanisms","volume":"5","author":"Tordjman","year":"2014","journal-title":"Front. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.111322_bib0175","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1289\/ehp.8483","article-title":"The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism","volume":"114","author":"Hertz-Picciotto","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.biopha.2021.111322_bib0180","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.3402\/ehtj.v4i0.7111","article-title":"Environmental risk factors for autism","volume":"4","author":"Dietert","year":"2011","journal-title":"Emerg. Health Threats J."},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajmg.c.30080","article-title":"Advances in autism neuroimaging research for the clinician and geneticist","volume":"142C","author":"Lainhart","year":"2006","journal-title":"Am. J. Med. Gene. Part C-Sem. Med. Gene."},{"key":"10.1016\/j.biopha.2021.111322_bib0195","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awg110","article-title":"Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys","volume":"126","author":"Herbert","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nrneurol.2013.276","article-title":"Neuroimaging in autism-from basic science to translational research","volume":"10","author":"Ecker","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2021.111322_bib0205","series-title":"The Neurobiology of Autism","first-page":"121","article-title":"Structural brain anatomy in autism: what is the evidence","author":"Bauman","year":"2005"},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0210","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/01.wnl.0000229923.08213.1e","article-title":"Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation","volume":"67","author":"Petropoulos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2021.111322_bib0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00500","article-title":"Aberrant development and synaptic transmission of cerebellar cortex in a VPA induced mouse autism model","volume":"12","author":"Wang","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2021.111322_bib0220","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.seizure.2011.06.012","article-title":"Antiepileptic drug use during pregnancy: perinatal outcomes","volume":"20","author":"Kulaga","year":"2011","journal-title":"Seizure-Euro. J. Epilepsy"},{"issue":"7","key":"10.1016\/j.biopha.2021.111322_bib0225","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.biopha.2021.111322_bib0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.reprotox.2018.05.006","article-title":"Is post exposure prevention of teratogenic damage possible: studies on diabetes, valproic acid, alcohol and anti folates in pregnancy: animal studies with reflection to human","volume":"80","author":"Ornoy","year":"2018","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.biopha.2021.111322_bib0235","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2015.03.004","article-title":"Prevention of valproic acid-induced neural tube defects by sildenafil citrate","volume":"56","author":"Tiboni","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/tera.1420410408","article-title":"Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate","volume":"41","author":"Turner","year":"1990","journal-title":"Teratology"},{"key":"10.1016\/j.biopha.2021.111322_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2016.06.001","article-title":"Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid","volume":"72","author":"Kazlauskas","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijdevneu.2009.01.006","article-title":"Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study","volume":"27","author":"Kuwagata","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0255","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2012.11.048","article-title":"Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus","volume":"1495","author":"Silvestrin","year":"2013","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0260","doi-asserted-by":"crossref","first-page":"293","DOI":"10.12965\/jer.1632696.348","article-title":"Treadmill exercise ameliorates motor dysfunction through inhibition of Purkinje cell loss in cerebellum of valproic acid-induced autistic rats","volume":"12","author":"Cho","year":"2016","journal-title":"J. Exerc. Rehabil."},{"key":"10.1016\/j.biopha.2021.111322_bib0265","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00023","article-title":"Late onset deficits in synaptic plasticity in the valproic acid rat model of autism","volume":"8","author":"Martin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0270","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111322_bib0275","article-title":"Plausibility of the zebrafish embryos\/larvae as an alternative animal model for autism: a comparison study of transcriptome changes","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111322_bib0280","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vascn.2018.11.006","article-title":"Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: an approach towards modeling autism","volume":"95","author":"Dwivedi","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.biopha.2021.111322_bib0285","doi-asserted-by":"crossref","DOI":"10.1186\/2040-2392-4-36","article-title":"SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)","volume":"4","author":"Abrahams","year":"2013","journal-title":"Mol. Autism"},{"key":"10.1016\/j.biopha.2021.111322_bib0290","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ntt.2015.10.002","article-title":"Embryological exposure to valproic acid induces social interaction deficits in zebrafish (Danio rerio): a developmental behavior analysis","volume":"52","author":"Zimmermann","year":"2015","journal-title":"Neurotoxicol. Teratol."},{"issue":"10","key":"10.1016\/j.biopha.2021.111322_bib0295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cns.12582","article-title":"Functional genomic analyses identify pathways dysregulated in animal model of autism","volume":"22","author":"Huang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2021.111322_bib0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.fct.2018.02.061","article-title":"Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA","volume":"115","author":"Hirsch","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2021.111322_bib0305","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2015.05.006","article-title":"Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism","volume":"80","author":"Loohuis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2021.111322_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2018.11.003","article-title":"mS-11, a mimetic of the mSin3-binding helix in NRSF, ameliorates social interaction deficits in a prenatal valproic acid-induced autism mouse model","volume":"176","author":"Kawase","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"39","key":"10.1016\/j.biopha.2021.111322_bib0315","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0320","first-page":"107","article-title":"Valproic acid silencing of ascl1b\/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome","volume":"7","author":"Jacob","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"5","key":"10.1016\/j.biopha.2021.111322_bib0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5607\/en.2017.26.5.252","article-title":"Valproic acid induces telomerase reverse transcriptase expression during cortical development","volume":"26","author":"Kim","year":"2017","journal-title":"Exp. Neurobiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111322_bib0330","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s11064-019-02903-4","article-title":"Increased expression of Kv10.2 in the hippocampus attenuates valproic acid-induced autism-like behaviors in rats","volume":"44","author":"Wang","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2021.111322_bib0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2017.08.018","article-title":"Valproic acid exposure decreases the mRNA stability of Bcl-2 via up-regulating miR-34a in the cerebellum of rat","volume":"657","author":"Dai","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0340","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00427-016-0561-4","article-title":"Developmental profiling of ASD-related shank3 transcripts and their differential regulation by valproic acid in zebrafish","volume":"226","author":"Liu","year":"2016","journal-title":"Dev. Genes Evol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0345","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s12035-014-9085-y","article-title":"Valproic acid influences MTNR1A intracellular trafficking and signaling in a beta-arrestin 2-Dependent manner","volume":"53","author":"Hong","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111322_bib0350","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpneuro0847","article-title":"The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders","volume":"4","author":"Pandi-Perumal","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.spen.2015.03.006","article-title":"Sleep in autism Spectrum disorder and attention deficit hyperactivity disorder","volume":"22","author":"Singh","year":"2015","journal-title":"Semin. Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12081","article-title":"Melatonin reverses the decreases in hippocampal protein serine\/threonine kinases observed in an animal model of autism","volume":"56","author":"Tian","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2021.111322_bib0365","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2016.06.007","article-title":"PI3K\/AKT\/mTOR-mediated autophagy in the development of autism spectrum disorder","volume":"125","author":"Zhang","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0370","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.neuropharm.2012.07.028","article-title":"Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3 beta\/beta-catenin pathway","volume":"63","author":"Go","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0375","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00213-017-4805-4","article-title":"Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory impairments in the valproic acid rat model of autism","volume":"235","author":"Wu","year":"2018","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0380","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.neuron.2014.09.001","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits (vol 83, pg 1131, 2014)","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"issue":"7508","key":"10.1016\/j.biopha.2021.111322_bib0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature13248","article-title":"Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission","volume":"511","author":"Karayannis","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2021.111322_bib0390","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.brs.2015.06.017","article-title":"Consensus paper: probing homeostatic plasticity of human cortex with non-invasive transcranial brain stimulation","volume":"8","author":"Karabanov","year":"2015","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpn.2016.07.007","article-title":"Cerebral plasticity: windows of opportunity in the developing brain","volume":"21","author":"Ismail","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0400","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15622975.2015.1085597","article-title":"Excitatory\/inhibitory imbalance in autism spectrum disorders: implications for interventions and therapeutics","volume":"17","author":"Uzunova","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0405","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.0021-9630.2003.00317.x","article-title":"Autism and pervasive developmental disorders","volume":"45","author":"Volkmar","year":"2004","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2021.111322_bib0410","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hbm.21085","article-title":"Altered intrinsic functional connectivity of anterior and posterior insula regions in high-functioning participants with autism Spectrum disorder","volume":"32","author":"Ebisch","year":"2011","journal-title":"Hum. Brain Mapp."},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0415","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00213-013-3290-7","article-title":"Biomarkers in autism spectrum disorder: the old and the new","volume":"231","author":"Ruggeri","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.npp.1301571","article-title":"Interaction between BDNF and serotonin: role in mood disorders","volume":"33","author":"Martinowich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2021.111322_bib0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mcn.2014.01.007","article-title":"Increased BDNF expression in fetal brain in the valproic acid model of autism","volume":"59","author":"Almeida","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0430","doi-asserted-by":"crossref","DOI":"10.1177\/1179069519859371","article-title":"What is excitation\/inhibition and how is it regulated? A case of the elephant and the wisemen","volume":"13","author":"He","year":"2019","journal-title":"J. Exp. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2021.111322_bib0435","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","article-title":"Excitation\/inhibition imbalance in animal models of autism spectrum disorders","volume":"81","author":"Lee","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.111322_bib0440","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2014.10.007","article-title":"NMDA receptor dysfunction in autism spectrum disorders","volume":"20","author":"Lee","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055248","article-title":"The amygdala excitatory\/inhibitory balance in a valproate-induced rat autism model","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111322_bib0450","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00213","article-title":"The liver X receptor agonist TO901317 ameliorates behavioral deficits in two mouse models of autism","volume":"13","author":"Cai","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0455","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.toxlet.2019.05.013","article-title":"Twenty-eight-day repeated oral doses of sodium valproic acid increases neural stem cells and suppresses differentiation of granule cell lineages in adult hippocampal neurogenesis of postpubertal rats","volume":"312","author":"Watanabe","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0460","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12640-016-9660-2","article-title":"Maternal exposure to valproic acid primarily targets interneurons followed by late effects on neurogenesis in the hippocampal dentate gyrus in rat offspring","volume":"31","author":"Watanabe","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2021.111322_bib0465","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.neuroscience.2019.02.022","article-title":"Protective effects of melatonin against valproic acid-induced memory impairments and reductions in adult rat hippocampal neurogenesis","volume":"406","author":"Aranarochana","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111322_bib0470","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbr.2016.10.004","article-title":"Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model","volume":"317","author":"Ha","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2021.111322_bib0475","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-014-0189-0","article-title":"GABAergic\/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders","volume":"11","author":"El-Ansary","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0480","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2011.08.007","article-title":"The role of immune dysfunction in the pathophysiology of autism","volume":"26","author":"Onore","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2021.111322_bib0485","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00121","article-title":"The impact of neuroimmune alterations in autism spectrum disorder","volume":"6","author":"Gottfried","year":"2015","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2021.111322_bib0490","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0495","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/aur.1338","article-title":"Altered peripheral and central inflammatory responses in a mouse model of autism","volume":"7","author":"Lucchina","year":"2014","journal-title":"Autism Res."},{"key":"10.1016\/j.biopha.2021.111322_bib0500","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-018-0254-0","article-title":"Neuroglia in the autistic brain: evidence from a preclinical model","volume":"9","author":"Bronzuoli","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.biopha.2021.111322_bib0505","series-title":"Molecular Basis of Neuropsychiatric Disorders: From Bench to Bedside","first-page":"223","article-title":"Microglia as possible therapeutic targets for autism spectrum disorders","author":"Andoh","year":"2019"},{"key":"10.1016\/j.biopha.2021.111322_bib0510","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00344","article-title":"Segmented Iba1-positive processes of microglia in autism model marmosets","volume":"13","author":"Sanagi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","article-title":"Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats","volume":"1630","author":"Kumar","year":"2016","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111322_bib0520","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/cns.13074","article-title":"Cathepsin B inhibition ameliorates leukocyte-endothelial adhesion in the BTBR mouse model of autism","volume":"25","author":"Wang","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2021.111322_bib0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104441","article-title":"Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: relevance for susceptibility and resilience in autism","volume":"110","author":"Kazlauskas","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2021.111322_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108775","article-title":"The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice","volume":"312","author":"Eissa","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2021.111322_bib0535","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","article-title":"Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder","volume":"91","author":"Kumar","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2021.111322_bib0540","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00367","article-title":"Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats","volume":"13","author":"Zamberletti","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2021.111322_bib0545","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.biocel.2010.06.001","article-title":"The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes","volume":"42","author":"Al-Gubory","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2021.111322_bib0550","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopha.2018.03.140","article-title":"Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases","volume":"102","author":"Taleb","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"21","key":"10.1016\/j.biopha.2021.111322_bib0555","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","article-title":"Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins","volume":"75","author":"Chauhan","year":"2004","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111322_bib0560","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/mol.111.072314","article-title":"Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects","volume":"80","author":"Tung","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"23","key":"10.1016\/j.biopha.2021.111322_bib0565","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.2174\/092986712802002572","article-title":"Glutathione-related factors and oxidative stress in autism, a review","volume":"19","author":"Ghanizadeh","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111322_bib0570","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2016.03.013","article-title":"The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder","volume":"324","author":"Li","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.111322_bib0575","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31385-7","article-title":"The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism","volume":"8","author":"Eissa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.111322_bib0580","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainresbull.2019.02.003","article-title":"Benefits of fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats","volume":"147","author":"Mirza","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0585","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2021.111322_bib0590","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijdevneu.2019.05.006","article-title":"Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-gamma agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats","volume":"76","author":"Mirza","year":"2019","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0595","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2018.00009","article-title":"Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid","volume":"10","author":"Fontes-Dutra","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.biopha.2021.111322_bib0600","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","article-title":"Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism","volume":"286","author":"Al-Amin","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111322_bib0605","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030521","article-title":"Autism spectrum disorders and the gut microbiota","volume":"11","author":"Fattorusso","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.biopha.2021.111322_bib0610","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/bies.201400075","article-title":"Altered brain-gut axis in autism: comorbidity or causative mechanisms?","volume":"36","author":"Mayer","year":"2014","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2021.111322_bib0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2016.03.013","article-title":"The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder","volume":"324","author":"Li","year":"2016","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.biopha.2021.111322_bib0620","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/dneu.22581","article-title":"Searching for the gut microbial contributing factors to social behavior in rodent models of autism spectrum disorder","volume":"78","author":"Needham","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.biopha.2021.111322_bib0625","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-018-0251-3","article-title":"The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism","volume":"9","author":"Liu","year":"2018","journal-title":"Mol. Autism"},{"issue":"2","key":"10.1016\/j.biopha.2021.111322_bib0630","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuron.2018.11.018","article-title":"Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder","volume":"101","author":"Sgritta","year":"2019","journal-title":"Neuron"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:32:41Z","timestamp":1760099561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":126,"alternative-id":["S0753332221001074"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111322","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111322"}}